Pulse Biosciences, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Pulse Biosciences announces its 2026 Annual Meeting of Stockholders, scheduled for June 11, 2026, to elect directors and ratify auditor appointments.
NASDAQ
Pulse Biosciences, Inc. announced its 2025 Annual Meeting of Stockholders to be held virtually on December 9, 2025, to vote on director elections, auditor ratification, executive compensation, and other corporate matters.
NASDAQ
Pulse Biosciences, Inc. has filed definitive additional proxy soliciting materials with the SEC.
NASDAQ
Pulse Biosciences will hold a special meeting to approve increasing its equity incentive plan by 2 million shares and ratify 1.1 million previously granted options.
NASDAQ
Pulse Biosciences has filed a definitive proxy statement with the SEC.
NASDAQ
Pulse Biosciences announces its 2024 annual meeting of stockholders to be held virtually on June 6, 2024, to elect directors and ratify the appointment of its independent accounting firm.